ND
Nathan Dau
Venture CapitalActiveGrowth & Private Equity Investor
79
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Nathan Dau.
Investment Thesis & Strategy
Nathan Dau invests in growth-stage and private equity healthcare companies, with a focus on health and hospital services and health IT. He seeks to invest in companies with high growth potential and strong market positions.
Portfolio Companies
Selected investments from their portfolio of 79 companies
Z
Zai Lab
Other · , 0
P
Provivi
Other · , 0
V
VYNE Therapeutics
Other · , 0
M
MEI Pharma
Other · , 0
C
Coherus Biosciences
Other · , 0
S
Satsuma Pharmaceuticals
Other · , 0
A
AirXpanders
Other · , 0
G
Genetron Health
Other · , 0
B
Bristol-Myers Squibb
Other · , 0
I
INBRACE
Other · , 0
R
Revolution Medicines
Other · , 0
P
Platelet BioGenesis
Other · , 0
Frequently Asked Questions
Nathan Dau focuses on Series B stage investments.
Related Investors
Index Ventures
San Francisco, United States · 827 deals
First Round Capital
San Francisco, United States · 742 deals
Benchmark
San Francisco, United States · 600 deals
Founders Fund
San Francisco, United States · 564 deals
Matrix Partners
San Francisco, United States · 549 deals
Bain Capital Ventures
San Francisco, United States · 438 deals